Eli Lilly and Co Update on SARS-CoV-2 Neutralizing Antibody Program - Conference Call Transcript - Thomson StreetEvents

Eli Lilly and Co Update on SARS-CoV-2 Neutralizing Antibody Program - Conference Call Transcript

Eli Lilly and Co Update on SARS-CoV-2 Neutralizing Antibody Program - Conference Call Transcript - Thomson StreetEvents
Eli Lilly and Co Update on SARS-CoV-2 Neutralizing Antibody Program - Conference Call Transcript
Published Jan 26, 2021
18 pages (11988 words) — Published Jan 26, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of LLY.N conference call or presentation 26-Jan-21 5:00pm GMT

  
Brief Excerpt:

...Operator Ladies and gentlemen, thank you for standing by. Welcome to the COVID-19 neutralizing antibody program update media and investor call. (Operator Instructions) As a reminder, this conference call is being recorded. (Operator Instructions) And I will now like to turn the conference over to our host, Kevin Hern. Please go ahead, sir. Kevin Hern ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Eli Lilly and Co
Ticker
LLY.N
Time
5:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Gregory B. Gilbert - Truist Securities, Inc., Research Division - Analyst : Thank you, team. Sorry if I missed this, but when would you be in a position where supply would not be an issue? I think you've commented on 2021 specifically, but at what point would supply not be an issue sort of regardless on the existing antibodies. And my second question is about vaccination. Some consumer research we've done very recently suggest that a pretty large portion of the U.S. population is not ready to get vaccinated, even if there is supply. Whether that's true or not or changes or not, how do vaccination rates shape REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.

Table Of Contents

Eli Lilly and Co at SVB Leerink Global Healthcare Conference (Virtual) Transcript – 2021-02-24 – US$ 54.00 – Edited Transcript of LLY.N presentation 24-Feb-21 6:40pm GMT

Eli Lilly and Co at Guggenheim Partners Healthcare Talks Oncology Days Transcript – 2021-02-12 – US$ 54.00 – Edited Transcript of LLY.N presentation 12-Feb-21 4:00pm GMT

Eli Lilly and Co Q4 2020 Earnings Call Summary – 2021-01-29 – US$ 54.00 – Edited Brief of LLY.N earnings conference call or presentation 29-Jan-21 2:00pm GMT

Eli Lilly and Co Q4 2020 Earnings Call Transcript – 2021-01-29 – US$ 54.00 – Edited Transcript of LLY.N earnings conference call or presentation 29-Jan-21 2:00pm GMT

Eli Lilly and Co Update on SARS-CoV-2 Neutralizing Antibody Program - Conference Call Summary – 2021-01-26 – US$ 54.00 – Edited Brief of LLY.N conference call or presentation 26-Jan-21 5:00pm GMT

Eli Lilly and Co at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-12 – US$ 54.00 – Edited Transcript of LLY.N presentation 12-Jan-21 1:20pm GMT

Eli Lilly and Co 2021 Guidance Call Summary – 2020-12-15 – US$ 54.00 – Edited Brief of LLY.N guidance conference call or presentation 15-Dec-20 1:30pm GMT

Eli Lilly and Co 2021 Guidance Call Transcript – 2020-12-15 – US$ 54.00 – Edited Transcript of LLY.N guidance conference call or presentation 15-Dec-20 1:30pm GMT

Eli Lilly and Co at Evercore ISI HealthCONx Conference (Virtual) Transcript – 2020-12-01 – US$ 54.00 – Edited Transcript of LLY.N presentation 1-Dec-20 7:40pm GMT

Eli Lilly and Co to Provide an Overview of Tirzepatide Phase 3 Clinical Program - Conference Call Summary – 2020-11-20 – US$ 54.00 – Edited Brief of LLY.N conference call or presentation 20-Nov-20 4:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Eli Lilly and Co Update on SARS-CoV-2 Neutralizing Antibody Program - Conference Call Transcript" Jan 26, 2021. Alacra Store. May 15, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Eli-Lilly-and-Co-Update-on-SARS-CoV-2-Neutralizing-Antibody-Program-Conference-Call-T13605109>
  
APA:
Thomson StreetEvents. (2021). Eli Lilly and Co Update on SARS-CoV-2 Neutralizing Antibody Program - Conference Call Transcript Jan 26, 2021. New York, NY: Alacra Store. Retrieved May 15, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Eli-Lilly-and-Co-Update-on-SARS-CoV-2-Neutralizing-Antibody-Program-Conference-Call-T13605109>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.